Market Closed -
Nasdaq
04:00:00 2024-05-20 pm EDT
|
5-day change
|
1st Jan Change
|
0.93
USD
|
+2.76%
|
|
-2.11%
|
-34.04%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
197.7
|
53.19
|
59.69
|
46.33
|
-
|
-
|
Enterprise Value (EV)
1 |
197.7
|
53.19
|
59.69
|
46.33
|
46.33
|
46.33
|
P/E ratio
|
-3.56
x
|
-0.88
x
|
-1.12
x
|
-0.94
x
|
-1.18
x
|
-2.16
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
395
x
|
141
x
|
24.6
x
|
8.26
x
|
2.91
x
|
0.94
x
|
EV / Revenue
|
395
x
|
141
x
|
24.6
x
|
8.26
x
|
2.91
x
|
0.94
x
|
EV / EBITDA
|
-7.21
x
|
-0.98
x
|
-1.3
x
|
-1.17
x
|
-1.33
x
|
-1.64
x
|
EV / FCF
|
-10.7
x
|
-1.74
x
|
-
|
-1.16
x
|
-1.72
x
|
-4.46
x
|
FCF Yield
|
-9.37%
|
-57.5%
|
-
|
-86.2%
|
-58.3%
|
-22.4%
|
Price to Book
|
3.43
x
|
2.39
x
|
-
|
-1.12
x
|
-0.62
x
|
-
|
Nbr of stocks (in thousands)
|
36,809
|
39,108
|
42,330
|
49,817
|
-
|
-
|
Reference price
2 |
5.370
|
1.360
|
1.410
|
0.9300
|
0.9300
|
0.9300
|
Announcement Date
|
3/28/22
|
3/14/23
|
3/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
0.5
|
0.377
|
2.428
|
5.606
|
15.93
|
49.25
|
EBITDA
1 |
-
|
-27.42
|
-54.24
|
-45.98
|
-39.63
|
-34.95
|
-28.3
|
EBIT
1 |
-
|
-27.42
|
-56.17
|
-48.48
|
-42.47
|
-39.31
|
-22.43
|
Operating Margin
|
-
|
-5,483.8%
|
-14,899.47%
|
-1,996.79%
|
-757.67%
|
-246.78%
|
-45.54%
|
Earnings before Tax (EBT)
1 |
-
|
-28.08
|
-56.17
|
-52.67
|
-43.03
|
-43.35
|
-32.85
|
Net income
1 |
-8.28
|
-28.08
|
-56.17
|
-52.67
|
-45.02
|
-40.97
|
-25.02
|
Net margin
|
-
|
-5,615.6%
|
-14,899.47%
|
-2,169.11%
|
-803.15%
|
-257.24%
|
-50.81%
|
EPS
2 |
-0.5882
|
-1.510
|
-1.550
|
-1.260
|
-0.9900
|
-0.7860
|
-0.4300
|
Free Cash Flow
1 |
-
|
-18.53
|
-30.59
|
-
|
-39.95
|
-27.01
|
-10.39
|
FCF margin
|
-
|
-3,706%
|
-8,114.85%
|
-
|
-712.71%
|
-169.58%
|
-21.09%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
9/22/21
|
3/28/22
|
3/14/23
|
3/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
0.3
|
0.189
|
-
|
0.076
|
0.112
|
0.446
|
0.159
|
0.783
|
1.04
|
1.001
|
1.247
|
1.501
|
1.874
|
1.633
|
2.233
|
EBITDA
1 |
-11.24
|
-12.25
|
-13.92
|
-13.76
|
-14.31
|
-15.68
|
-10.66
|
-13.55
|
-10.82
|
-10.17
|
-9.433
|
-9.533
|
-9.6
|
-9.467
|
-9.9
|
EBIT
1 |
-11.24
|
-12.77
|
-14.62
|
-14.35
|
-14.93
|
-14.32
|
-11.58
|
-11.13
|
-11.45
|
-10.79
|
-10.4
|
-10.52
|
-10.6
|
-11.07
|
-10.83
|
Operating Margin
|
-3,747%
|
-6,756.61%
|
-
|
-18,880.26%
|
-13,328.57%
|
-3,210.09%
|
-7,285.53%
|
-1,421.2%
|
-1,101.25%
|
-1,078.12%
|
-834.19%
|
-700.92%
|
-565.74%
|
-677.55%
|
-485.08%
|
Earnings before Tax (EBT)
1 |
-11.31
|
-12.27
|
-14.62
|
-14.35
|
-14.93
|
-16.25
|
-11.38
|
-14.21
|
-10.83
|
-10.61
|
-10.5
|
-10.9
|
-11.2
|
-11.55
|
-11.6
|
Net income
1 |
-11.31
|
-12.27
|
-14.62
|
-14.35
|
-14.93
|
-16.25
|
-11.38
|
-14.21
|
-10.83
|
-18.11
|
-10.36
|
-10.63
|
-10.84
|
-11.9
|
-11.67
|
Net margin
|
-3,768.67%
|
-6,492.06%
|
-
|
-18,880.26%
|
-13,328.57%
|
-3,642.83%
|
-7,157.86%
|
-1,814.56%
|
-1,041.35%
|
-1,808.99%
|
-831.46%
|
-708.38%
|
-578.26%
|
-728.57%
|
-522.39%
|
EPS
2 |
-0.3200
|
-0.3500
|
-0.4100
|
-0.3900
|
-0.4000
|
-0.4000
|
-0.2700
|
-0.3400
|
-0.2500
|
-0.4000
|
-0.2250
|
-0.2275
|
-0.2200
|
-0.2267
|
-0.2100
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/28/22
|
5/11/22
|
8/15/22
|
11/14/22
|
3/14/23
|
5/15/23
|
8/14/23
|
11/13/23
|
3/25/24
|
5/13/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-18.5
|
-30.6
|
-
|
-40
|
-27
|
-10.4
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
1.570
|
0.5700
|
-
|
-0.8300
|
-1.490
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
0.86
|
0.91
|
-
|
1.29
|
2.4
|
4.1
|
Capex / Sales
|
-
|
172.4%
|
240.85%
|
-
|
22.98%
|
15.09%
|
8.32%
|
Announcement Date
|
9/22/21
|
3/28/22
|
3/14/23
|
3/25/24
|
-
|
-
|
-
|
Last Close Price
0.93
USD Average target price
3.833
USD Spread / Average Target +312.19% Consensus |
1st Jan change
|
Capi.
|
---|
| -34.04% | 46.33M | | +73.10% | 12.38B | | -19.92% | 7.81B | | +8.05% | 6.72B | | +12.49% | 5.39B | | +40.80% | 5.03B | | -17.92% | 4.72B | | -22.01% | 4.06B | | -28.94% | 2.68B | | +61.09% | 2.59B |
Medical Equipment
|